Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia
Clinical trial NCT04652726 · COMPLETED
Trial details
- NCT number
- NCT04652726
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-27
- Primary completion
- 2023-11-09
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.